<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Development / Dossiers &#8211; Polypharma: Generics Developer</title>
	<atom:link href="https://polypharma.de/en/category/development-dossiers/feed/" rel="self" type="application/rss+xml" />
	<link>https://polypharma.de</link>
	<description>Full-service in the production of generics and delivery of raw materials in Africa and the Middle East</description>
	<lastBuildDate>Wed, 29 Sep 2021 10:56:33 +0000</lastBuildDate>
	<language>en-GB</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://polypharma.de/wp-content/uploads/2020/07/cropped-Polypharma-Technologies-and-Sciences-Hamburg-150x150.png</url>
	<title>Development / Dossiers &#8211; Polypharma: Generics Developer</title>
	<link>https://polypharma.de</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Polypharma celebrates 30th Anniversary</title>
		<link>https://polypharma.de/en/2021/06/polypharma-celebrates-30th-anniversary/</link>
		
		<dc:creator><![CDATA[Liza Knezlova]]></dc:creator>
		<pubDate>Fri, 18 Jun 2021 08:27:42 +0000</pubDate>
				<category><![CDATA[Counterfeit Medicines]]></category>
		<category><![CDATA[Development / Dossiers]]></category>
		<category><![CDATA[Factory construction]]></category>
		<category><![CDATA[Fairs / Events]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Innovation]]></category>
		<category><![CDATA[Manufacturing Process]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[Pharmaceutical Raw Materials / Laboratory Equipment]]></category>
		<category><![CDATA[Registration Process]]></category>
		<category><![CDATA[30 years]]></category>
		<category><![CDATA[30th anniversary]]></category>
		<category><![CDATA[Africa]]></category>
		<category><![CDATA[biosimilar]]></category>
		<category><![CDATA[construction]]></category>
		<category><![CDATA[Consultant]]></category>
		<category><![CDATA[Developer]]></category>
		<category><![CDATA[Dossier development]]></category>
		<category><![CDATA[drug]]></category>
		<category><![CDATA[Drug Master File]]></category>
		<category><![CDATA[food supplements]]></category>
		<category><![CDATA[generic manufacture]]></category>
		<category><![CDATA[MENA]]></category>
		<category><![CDATA[Middle East]]></category>
		<category><![CDATA[Polypharma]]></category>
		<category><![CDATA[Polypharma tech]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[raw material]]></category>
		<category><![CDATA[Sciences]]></category>
		<category><![CDATA[sourcing]]></category>
		<category><![CDATA[supply]]></category>
		<category><![CDATA[Technologies]]></category>
		<guid isPermaLink="false">https://polypharma.de/?p=8650</guid>

					<description><![CDATA[Single partner Polypharma offers a unique blend of services and skills that make it possible for it to act as a single partner accompanying local companies all the way from selection of target product through to actual receipt of raw materials for production. “Over the years we have developed more than 200 approved drug dossiers [&#8230;]]]></description>
		
		
		
			</item>
		<item>
		<title>Sodium hyaluronate 0.3% Serum</title>
		<link>https://polypharma.de/en/2021/01/sodium-hyaluronate-0-3-serum-2/</link>
		
		<dc:creator><![CDATA[Liza Knezlova]]></dc:creator>
		<pubDate>Fri, 29 Jan 2021 15:04:49 +0000</pubDate>
				<category><![CDATA[Development / Dossiers]]></category>
		<category><![CDATA[Dossier development]]></category>
		<category><![CDATA[hyaluronic acid]]></category>
		<category><![CDATA[Polypharma]]></category>
		<category><![CDATA[sodium hyaluronate]]></category>
		<category><![CDATA[tech transfer]]></category>
		<category><![CDATA[technical transfer]]></category>
		<guid isPermaLink="false">https://polypharma.de/?p=7931</guid>

					<description><![CDATA[Polypharma has developed a Sodium hyaluronate 0.3% serum. Sodium hyaluronate, as hyaluronic acid, is a natural component of the skin and is used to smooth and tighten the skin, as well as to moisturise it.]]></description>
		
		
		
			</item>
		<item>
		<title>Dossiers Betamethasone dipropionate 0.05% Lotion and Creme</title>
		<link>https://polypharma.de/en/2020/12/dossiers-betamethasone-dipropionate-lotion-and-creme-2/</link>
		
		<dc:creator><![CDATA[Liza Knezlova]]></dc:creator>
		<pubDate>Tue, 15 Dec 2020 15:02:13 +0000</pubDate>
				<category><![CDATA[Development / Dossiers]]></category>
		<category><![CDATA[betamethasone]]></category>
		<category><![CDATA[betamethasone dipropionate]]></category>
		<category><![CDATA[dossiers]]></category>
		<category><![CDATA[Know How]]></category>
		<category><![CDATA[Polypharma]]></category>
		<category><![CDATA[Polypharma Technologies & Sciences GmbH]]></category>
		<category><![CDATA[tech transfer]]></category>
		<category><![CDATA[technical dossiers]]></category>
		<category><![CDATA[technical transfer]]></category>
		<category><![CDATA[technology transfer]]></category>
		<guid isPermaLink="false">https://polypharma.de/?p=7925</guid>

					<description><![CDATA[The technical dossiers for Betamethasone dipropionate 0.05% lotion and Betamethasone dipropionate cream have been completed by Polypharma. This glucocorticoid is used to treat dermatitis, eczema and psoriasis.]]></description>
		
		
		
			</item>
		<item>
		<title>Terbinafine hydrochloride 1% solution</title>
		<link>https://polypharma.de/en/2020/11/terbinafine-hydrochloride-1-solution/</link>
		
		<dc:creator><![CDATA[Liza Knezlova]]></dc:creator>
		<pubDate>Mon, 16 Nov 2020 14:59:00 +0000</pubDate>
				<category><![CDATA[Development / Dossiers]]></category>
		<category><![CDATA[antifungal]]></category>
		<category><![CDATA[antifungal agent]]></category>
		<category><![CDATA[dossier]]></category>
		<category><![CDATA[Dossier development]]></category>
		<category><![CDATA[Polypharma]]></category>
		<category><![CDATA[Polypharma tech]]></category>
		<category><![CDATA[Polypharma Technologies & Sciences GmbH]]></category>
		<category><![CDATA[technical dossiers]]></category>
		<category><![CDATA[Terbinafine]]></category>
		<category><![CDATA[Terbinafine hydrochloride]]></category>
		<category><![CDATA[Terbinafine hydrochloride spray]]></category>
		<category><![CDATA[Terbinafine Spray]]></category>
		<guid isPermaLink="false">https://polypharma.de/?p=7919</guid>

					<description><![CDATA[Polypharma has developed a Terbinafine hydrochloride 1% spray solution for topical application. Terbinafine is an antifungal agent and the most commonly used treatment for skin and foot fungal infections.]]></description>
		
		
		
			</item>
		<item>
		<title>Diclofenac diethylamine 1% gel</title>
		<link>https://polypharma.de/en/2020/09/diclofenac-diethylamine-1-gel-2/</link>
		
		<dc:creator><![CDATA[Liza Knezlova]]></dc:creator>
		<pubDate>Tue, 15 Sep 2020 14:55:39 +0000</pubDate>
				<category><![CDATA[Development / Dossiers]]></category>
		<guid isPermaLink="false">https://polypharma.de/?p=7913</guid>

					<description><![CDATA[Polypharma has completed the preparation of a technical dossier for a gel based on 1% diethylamine diclofenac. Diclofenac diethylamine has an analgesic, anti-inflammatory and refreshing effect. It can be used to treat sports injuries, sunburn and arthritis.]]></description>
		
		
		
			</item>
		<item>
		<title>Calcipotriol ointment developed</title>
		<link>https://polypharma.de/en/2020/09/calcipotriol-ointment-developed/</link>
		
		<dc:creator><![CDATA[Liza Knezlova]]></dc:creator>
		<pubDate>Thu, 03 Sep 2020 11:42:12 +0000</pubDate>
				<category><![CDATA[Development / Dossiers]]></category>
		<guid isPermaLink="false">https://polypharma.de/?p=6621</guid>

					<description><![CDATA[With this ointment Polypharma is also expanding its portfolio of dermatology products. A product extremely effective for the external treatment of psoriasis. This D3 derivative disrupts the growth and proliferation of keratinocytes and improves the disturbed cell separation.]]></description>
		
		
		
			</item>
		<item>
		<title>Fusidic acid and betamethasone creme developed</title>
		<link>https://polypharma.de/en/2020/08/fusidic-acid-and-betamethasone-creme-developed/</link>
		
		<dc:creator><![CDATA[Liza Knezlova]]></dc:creator>
		<pubDate>Wed, 12 Aug 2020 11:41:27 +0000</pubDate>
				<category><![CDATA[Development / Dossiers]]></category>
		<guid isPermaLink="false">https://polypharma.de/?p=6619</guid>

					<description><![CDATA[Polypharma has developed a cream containing the active ingredients fusidic acid and betamethasone. While fusidic acid is known to help with bacterial infections of the skin, betamethasone helps with skin diseases such as psoriasis, neurodermatitis and hives. It is well known that in patients with neurodermatitis, bacteria often occur on the skin, causing inflammation and [&#8230;]]]></description>
		
		
		
			</item>
		<item>
		<title>Terbinafine 250mg tablet</title>
		<link>https://polypharma.de/en/2020/06/terbinafine-250mg-tablet/</link>
		
		<dc:creator><![CDATA[Liza Knezlova]]></dc:creator>
		<pubDate>Wed, 10 Jun 2020 11:30:28 +0000</pubDate>
				<category><![CDATA[Development / Dossiers]]></category>
		<guid isPermaLink="false">https://polypharma.de/?p=6596</guid>

					<description><![CDATA[Polypharma has developed a Terbinafine 250mg tablet. Terbinafine is an antimycotic and is the most common medication for skin and foot fungus.]]></description>
		
		
		
			</item>
		<item>
		<title>Thiocolchicoside 4mg capsules</title>
		<link>https://polypharma.de/en/2020/05/thiocolchicoside-4mg-capsules/</link>
		
		<dc:creator><![CDATA[Liza Knezlova]]></dc:creator>
		<pubDate>Tue, 05 May 2020 11:15:15 +0000</pubDate>
				<category><![CDATA[Development / Dossiers]]></category>
		<category><![CDATA[dossier]]></category>
		<category><![CDATA[Dossier development]]></category>
		<category><![CDATA[muscle relaxant]]></category>
		<category><![CDATA[Polypharma]]></category>
		<category><![CDATA[Polypharma tech]]></category>
		<category><![CDATA[Polypharma Technologies & Sciences GmbH]]></category>
		<category><![CDATA[technical dossiers]]></category>
		<category><![CDATA[Thiocolchicoside]]></category>
		<guid isPermaLink="false">https://polypharma.de/?p=6572</guid>

					<description><![CDATA[Polypharma has recently developed Thiocolchicoside 4mg capsules. Thiocolchicoside is a muscle relaxant with anti-inflammatory, analgesic and antispasmodic effects. It acts as a competitive GABAA receptor antagonist and also as a glycine receptor antagonist and to a lesser extent as a nicotinic acetylcholine receptor.]]></description>
		
		
		
			</item>
		<item>
		<title>Pregabalin know-how</title>
		<link>https://polypharma.de/en/2020/02/pregabalin-know-how/</link>
		
		<dc:creator><![CDATA[Liza Knezlova]]></dc:creator>
		<pubDate>Mon, 03 Feb 2020 10:30:25 +0000</pubDate>
				<category><![CDATA[Development / Dossiers]]></category>
		<guid isPermaLink="false">https://polypharma.de/?p=6526</guid>

					<description><![CDATA[Polypharma has completed the development of a Pregabalin 300mg capsule dossier]]></description>
		
		
		
			</item>
		<item>
		<title>Fusidic Acid know-how</title>
		<link>https://polypharma.de/en/2020/01/fusidic-acid-know-how/</link>
		
		<dc:creator><![CDATA[Liza Knezlova]]></dc:creator>
		<pubDate>Mon, 20 Jan 2020 10:18:34 +0000</pubDate>
				<category><![CDATA[Development / Dossiers]]></category>
		<guid isPermaLink="false">https://polypharma.de/?p=6512</guid>

					<description><![CDATA[Fusidic Acid Cream has been added to the Polypharma dossier portfolio]]></description>
		
		
		
			</item>
	</channel>
</rss>
